Mode
Text Size
Log in / Sign up
N/A N=37 Treatment

EMPOWER: Empowering the Management of Pain-Obesity-Weight Through Enhanced Reward

Low Back Pain

Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcome: Primary: Session-level Engagement (NOTE: This is a Pilot Study and There is Not a True Primary Outcome. There Are Several Descriptive Outcomes That Will Inform Our Decision to Proceed to a Traditional, Fully Powered Clinical Trial). — 6.9 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
In-Person (or Remote) Intervention (Behavioral)
Age
Adult, Older Adult · 45+ yrs
Sex
All
Sponsor
University of Florida
Primary completion
Jan 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Session-level Engagement (NOTE: This is a Pilot Study and There is Not a True Primary Outcome. There Are Several Descriptive Outcomes That Will Inform Our Decision to Proceed to a Traditional, Fully Powered Clinical Trial).
6.9
PRIMARY
Global Treatment Engagement
17
PRIMARY
Participant Satisfaction
3.7
PRIMARY
Participant Satisfaction
3.7
PRIMARY
Treatment Credibility
7.8
PRIMARY
Enrollment Rate
0.52
PRIMARY
Enrollment Rate
0.52
PRIMARY
Participant Retention
19
SECONDARY
Body Weight Change
-2.89
SECONDARY
Pain Impact Change
-4.0
SECONDARY
Pleasant Activity Engagement
64.7; 28.0
SECONDARY
Meaningful Activity Participation Change
6.36
SECONDARY
Global Treatment Engagement
17

Summary

The central objective of research is to examine the feasibility and acceptability of an 8-month single-arm behavioral intervention (i.e., EMPOWER) among overweight/obese middle-aged and older adults with moderate-to-high impact low back pain. Intervention content will focus on standard behavioral weight loss treatment and cognitive-behavioral pain coping therapy with a focus on environmental reward and positive affect.

Eligibility Criteria

Inclusion Criteria

  • 45-80 years of age
  • Have a BMI≥25kg/m2
  • Endorse pain in the lower back region (i.e., space between the lower posterior margin of the rib cage and the horizontal gluteal fold), knees, or hips
  • Pain must occur on at least 50% of the days in the previous six months
  • Pain must be rated, at minimum, of moderate intensity (rating of 3 on a numeric rating scale ranging from 0-10)
  • Pain impact must be rated as moderate to severe
  • Study physician reviews medical record and declares patient medically appropriate for exercise protocol

Exclusion Criteria

  • Current participation in another psychological treatment or structured weight loss program
  • Severe psychiatric illness not adequately controlled by medication or other conditions anticipated to impair intervention engagement (e.g., substance abuse/dependence)
  • Presence of chronic, malignant pain (e.g., cancer)
  • Significant cognitive impairment ( 4 weeks prior to the baseline assessment
  • Blood pressure higher than 180/100 mm Hg at baseline assessment
  • Has had bariatric surgery in the past year or is planning to have it in the next year
  • If participant reports the presence of systemic inflammatory disease (e.g., rheumatoid arthritis), the study physician will be consulted to determine eligibility
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04851587). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search